Free Trial

Cosmos Health Q4 2023 Earnings Report

Cosmos Health logo
$0.52 +0.04 (+7.14%)
As of 03:59 PM Eastern

Cosmos Health EPS Results

Actual EPS
$0.10
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

Cosmos Health Revenue Results

Actual Revenue
$15.84 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

Cosmos Health Announcement Details

Quarter
Q4 2023
Time
N/A

Conference Call Resources

Cosmos Health Earnings Headlines

How does space travel affect astronaut health?
Alert: DOGE goes live
"It's Elon's world, and the rest of us live in it." Every investor in America is trying to figure out what he might do next. And one widely followed Boston based think tank is stepping forward with their official playbook.
Cosmos Health will not proceed with offering under Form S-1
See More Cosmos Health Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Cosmos Health? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Cosmos Health and other key companies, straight to your email.

About Cosmos Health

Cosmos Health (NASDAQ:COSM) manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names. The company serves wholesale distributors and other healthcare providers, such as clinics, government agencies, independent retail and specialty pharmacies and independent specialty distributors. It sells its products through independent wholesale distributors. Cosmos Health Inc. was incorporated in 2009 and is headquartered in Chicago, Illinois.

View Cosmos Health Profile

More Earnings Resources from MarketBeat